Comments There is no doubt that social support improves cancer patients outcomes. This report talks about a study of married and unmarried patients survival rates. It found unmarried males and females had higher death rates that those who were married. New research has uncovered a link between being married and living longer among cancer patients, with the beneficial effect of marriage differing by race/ethnicity and place of birth. Published early online in CANCER, the findings have important public health implications, given the rising numbers of unmarried individuals in addition to… Read more Being Married helps prolong survival in cancer patients →
A few tips on how to achieve optimal prostate health
By Alice Archer More than 8 million Australians (almost one in three people) will be in the “crosshairs” of bowel cancer in just 10 years. That’s the finding of a disturbing new report released on Monday by leading social demographer Bernard Salt, who says by 2026, 4.6 million baby boomers and 4 million Gen Xers “will be subjected to a bowel cancer lottery” purely because of their age. “Bowel cancer attacks the middle-aged with progressive lethality, with rates leaping tenfold between the ages of 50 and 79,” he says. The report examines the rising… Read more Millions of Australians at risk of bowel cancer →
A population-based cohort study of cancer in 32,247 type 2 diabetes mellitus (T2DM) patients. •T2DM patients had an overall 28% significantly higher cancer risk. •Particularly elevated risks were found for liver and pancreas carcinomas. •T2DM patients with breast cancer had a lower 5-year survival probability than breast cancer patients without diabetes. Diabetes mellitus (DM) is associated with an elevated risk of cancer. The aim of this study was to assess cancer risk and survival in individuals with type 2 DM (T2DM) in Friuli Venezia Giulia, Italy. A retrospective population-based… Read more New Study: Type II diabetes patients overall cancer risk is 28% higher →
Comment This is a great article to remind us what risk really means when we talk about the probability of getting cancer. Ian Olver, University of South Australia Absolute risk is the risk of developing a cancer over a certain period of time. Relative risk is the risk one group of people has of developing a cancer compared to the risk of another group. The Conversation’s cancer map shows that the risk of bowel cancer is 10% higher for men and women who have one standard alcoholic drink every day,… Read more IT’S ALL RELATIVE : How to understand cancer risk →
Less than 10% cancers are genetic,which means 90% are due to epigenetic factors. We know some of the reasons why people get cancer later in life and these can be easy to change. This is a great online tool to show you how some of the lifestyle choices you make can increase or decrease cancer risk. https://theconversation.com/interactive-body-map-what-really-gives-you-cancer-52427
Traditional herbal medicine as an adjuvant treatment for non-small-cell lung cancer: A systematic review and meta-analysis Introduction Non-small-cell lung cancer (NSCLC) is one of the most common cancers and the leading cause of cancer-related deaths. In East Asia, traditional herbal medicine (THM) is commonly used in clinical settings for the treatment of cancer. Therefore, the aim of the present review was to systematically assess the efficacy of THM with varied components for the treatment of NSCLC. Methods This study identified randomized controlled trials (RCTs) that evaluated the effectiveness of combined… Read more Traditional Chinese Medicine Significantly Improves Quality of Life in Lung Cancer Patients →
doi:10.1016/j.eujim.2015.10.012 Introduction Drug associated liver injury is common and anticancer agents have been associated with inducing liver dysfunction, too. The present study was designed to evaluate the effect of silymarin (Milk Thistle) in reducing the hepatic side effects of taxane when used in chemotherapy of breast cancer. Methods This study was conducted on 99 patients with invasive breast carcinoma receiving chemotherapy contained adriamycin, epirubicin, cyclophosphamide, docetaxel, and paclitaxel. The patients were randomized into 2 groups and given silymarin 70 mg PO three times daily or placebo during their treatment course. The… Read more Silymarin (Milk Thistle) can revoke liver enzyme changes during chemotherapy of breast cancer with Taxanes →
